Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stop Hep B @ Birth
NCT04998838Unknown
- Sponsor
- Myanmar Liver Foundation
- Start
- Jul 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tenofovir disoproxil fumarate in hepatitis B (HBV), sponsored by Myanmar Liver Foundation. Primary endpoints: Vaccine within 24 hours, Effective treatment of pregnant women at 9 months and 1 more. Status: unknown.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT04998838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04998838.